Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Rosti

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
American Journal of Clinical Oncology|December 15, 2004
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experienceUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.
Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumoursSalvatore Luca Burgio, Cecilia Menna, Giorgio Papiani, et al.
Cancer Investigation|May 15, 2003
A high cytosol value of urokinase-type plasminogen activator (uPA) may be predictive of early relapse in primary breast cancerClaudio Dazzi, Anna Cariello, Patrizia Maioli, et al.
Drugs in Context|November 7, 2022
Nutritional support management in resectable gastric cancerFrancesco Serra, Paolo Pedrazzoli, Silvia Brugnatelli, et al.
International Journal of Molecular Sciences|June 10, 2023
Spermatocytic Tumor: A ReviewSimona Secondino, Alessandra Viglio, Giuseppe Neri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?Giuseppe Luigi Banna, Ugo De Giorgi, Benvenuto Ferrari, et al.
Advances in Therapy|July 23, 2011
Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panelAndrea Pession, Riccardo Masetti, Gianluca Gaidano, et al.
Frontiers in Oncology|October 3, 2022
Testicular tumors in the "elderly" populationSimona Secondino, Giovanni Rosti, Antonino C Tralongo, et al.
Critical Reviews in Oncology/Hematology|June 7, 2003
Prevention and therapy of neutropenia in elderly patientsGiovanni Rosti, Barbara Kopf, Anna Cariello, et al.
Frontiers in Endocrinology|May 10, 2021
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical CarcinomaDeborah Cosentini, Antonella Turla, Ornella Carminati, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Oncology|December 15, 2004
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experienceUgo De Giorgi, Giovanni Rosti, Giorgio Papiani, et al.
Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumoursSalvatore Luca Burgio, Cecilia Menna, Giorgio Papiani, et al.
Cancer Investigation|May 15, 2003
A high cytosol value of urokinase-type plasminogen activator (uPA) may be predictive of early relapse in primary breast cancerClaudio Dazzi, Anna Cariello, Patrizia Maioli, et al.
Drugs in Context|November 7, 2022
Nutritional support management in resectable gastric cancerFrancesco Serra, Paolo Pedrazzoli, Silvia Brugnatelli, et al.
International Journal of Molecular Sciences|June 10, 2023
Spermatocytic Tumor: A ReviewSimona Secondino, Alessandra Viglio, Giuseppe Neri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?Giuseppe Luigi Banna, Ugo De Giorgi, Benvenuto Ferrari, et al.
Advances in Therapy|July 23, 2011
Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panelAndrea Pession, Riccardo Masetti, Gianluca Gaidano, et al.
Frontiers in Oncology|October 3, 2022
Testicular tumors in the "elderly" populationSimona Secondino, Giovanni Rosti, Antonino C Tralongo, et al.
Critical Reviews in Oncology/Hematology|June 7, 2003
Prevention and therapy of neutropenia in elderly patientsGiovanni Rosti, Barbara Kopf, Anna Cariello, et al.
Frontiers in Endocrinology|May 10, 2021
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical CarcinomaDeborah Cosentini, Antonella Turla, Ornella Carminati, et al.
Pageof 9